Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by symbiont of host defense response (GO:0052031) | 6.16618211 |
2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.16618211 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.16618211 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.16618211 |
5 | modulation by symbiont of host immune response (GO:0052553) | 6.16618211 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.16618211 |
7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.03655199 |
8 | macrophage activation involved in immune response (GO:0002281) | 4.92044792 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.44695503 |
10 | detection of other organism (GO:0098543) | 4.27901004 |
11 | response to host immune response (GO:0052572) | 4.18373269 |
12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.18373269 |
13 | positive regulation of interferon-alpha production (GO:0032727) | 4.15457320 |
14 | detection of external biotic stimulus (GO:0098581) | 4.01660124 |
15 | regulation of interferon-alpha production (GO:0032647) | 3.97563454 |
16 | microglial cell activation (GO:0001774) | 3.93818811 |
17 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.92605301 |
18 | response to host (GO:0075136) | 3.92605301 |
19 | response to host defenses (GO:0052200) | 3.92605301 |
20 | detection of bacterium (GO:0016045) | 3.86611704 |
21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.73380052 |
22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.66963622 |
23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62889185 |
24 | I-kappaB phosphorylation (GO:0007252) | 3.59531244 |
25 | leukocyte aggregation (GO:0070486) | 3.58941089 |
26 | detection of biotic stimulus (GO:0009595) | 3.54532377 |
27 | response to peptidoglycan (GO:0032494) | 3.54042764 |
28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.42231586 |
29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38341520 |
30 | macrophage activation (GO:0042116) | 3.29816355 |
31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.27848017 |
32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21123934 |
33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19505370 |
34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.18699013 |
35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15139191 |
36 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.14810435 |
37 | neutrophil mediated immunity (GO:0002446) | 3.14774830 |
38 | neutrophil activation involved in immune response (GO:0002283) | 3.14043163 |
39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10349547 |
40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.06844332 |
41 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.06635391 |
42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05664175 |
43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02654837 |
44 | regulation of cholesterol storage (GO:0010885) | 2.98023178 |
45 | regulation of mast cell activation (GO:0033003) | 2.97758552 |
46 | response to interleukin-15 (GO:0070672) | 2.97588922 |
47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.96842349 |
48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.96487594 |
49 | immunoglobulin mediated immune response (GO:0016064) | 2.96153730 |
50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.95288122 |
51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95288122 |
52 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94120516 |
53 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92686628 |
54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92561637 |
55 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.91922829 |
56 | T-helper 1 type immune response (GO:0042088) | 2.91257544 |
57 | positive thymic T cell selection (GO:0045059) | 2.90272172 |
58 | myeloid cell activation involved in immune response (GO:0002275) | 2.89970556 |
59 | defense response to protozoan (GO:0042832) | 2.87804631 |
60 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87751572 |
61 | negative regulation of cell killing (GO:0031342) | 2.86386742 |
62 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86386742 |
63 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85572943 |
64 | regulation of T cell tolerance induction (GO:0002664) | 2.84862620 |
65 | regulation of tolerance induction (GO:0002643) | 2.83744499 |
66 | myeloid leukocyte mediated immunity (GO:0002444) | 2.81466302 |
67 | positive regulation of interferon-beta production (GO:0032728) | 2.81004378 |
68 | negative thymic T cell selection (GO:0045060) | 2.76627106 |
69 | myeloid leukocyte activation (GO:0002274) | 2.75564676 |
70 | respiratory burst (GO:0045730) | 2.75472005 |
71 | apoptotic cell clearance (GO:0043277) | 2.75093153 |
72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.74778161 |
73 | low-density lipoprotein particle clearance (GO:0034383) | 2.74012201 |
74 | negative T cell selection (GO:0043383) | 2.71052245 |
75 | response to muramyl dipeptide (GO:0032495) | 2.67993732 |
76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.67832939 |
77 | T cell migration (GO:0072678) | 2.67309178 |
78 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.66712247 |
79 | regulation of B cell differentiation (GO:0045577) | 2.66642781 |
80 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.65919230 |
81 | dendritic cell migration (GO:0036336) | 2.64731521 |
82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64133315 |
83 | response to protozoan (GO:0001562) | 2.62495341 |
84 | granulocyte activation (GO:0036230) | 2.62027483 |
85 | positive T cell selection (GO:0043368) | 2.61605839 |
86 | negative regulation of interleukin-12 production (GO:0032695) | 2.61522611 |
87 | B cell receptor signaling pathway (GO:0050853) | 2.61509145 |
88 | dendritic cell chemotaxis (GO:0002407) | 2.61407206 |
89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.61041549 |
90 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.60623564 |
91 | detection of molecule of bacterial origin (GO:0032490) | 2.59734737 |
92 | positive regulation of B cell differentiation (GO:0045579) | 2.56277666 |
93 | mannose metabolic process (GO:0006013) | 2.54877563 |
94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52866736 |
95 | germinal center formation (GO:0002467) | 2.52745507 |
96 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51776765 |
97 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.50185948 |
98 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49805924 |
99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49785228 |
100 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.49383278 |
101 | complement activation, alternative pathway (GO:0006957) | 2.47845461 |
102 | neutrophil activation (GO:0042119) | 2.46872647 |
103 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.43980387 |
104 | cellular extravasation (GO:0045123) | 2.43180085 |
105 | lipoprotein transport (GO:0042953) | 2.40234522 |
106 | cell adhesion mediated by integrin (GO:0033627) | 2.39658754 |
107 | plasma lipoprotein particle clearance (GO:0034381) | 2.39111141 |
108 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38625270 |
109 | positive regulation of phagocytosis (GO:0050766) | 2.38467948 |
110 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.37463644 |
111 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.36960661 |
112 | positive regulation of mast cell degranulation (GO:0043306) | 2.36960661 |
113 | positive regulation of leukocyte degranulation (GO:0043302) | 2.35363310 |
114 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.33667219 |
115 | regulation of leukocyte degranulation (GO:0043300) | 2.33394575 |
116 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.33255666 |
117 | response to type I interferon (GO:0034340) | 2.33098455 |
118 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.32945216 |
119 | negative regulation of interleukin-17 production (GO:0032700) | 2.32240154 |
120 | regulation of mast cell degranulation (GO:0043304) | 2.31810759 |
121 | positive regulation of mast cell activation (GO:0033005) | 2.31548518 |
122 | regulation of phagocytosis (GO:0050764) | 2.31026874 |
123 | type I interferon signaling pathway (GO:0060337) | 2.30079290 |
124 | cellular response to type I interferon (GO:0071357) | 2.30079290 |
125 | positive regulation of heat generation (GO:0031652) | 2.28894529 |
126 | regulation of podosome assembly (GO:0071801) | 2.28024776 |
127 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.26551789 |
128 | phospholipid homeostasis (GO:0055091) | 2.26089019 |
129 | mature B cell differentiation (GO:0002335) | 2.25997799 |
130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.24570065 |
131 | regulation of mononuclear cell migration (GO:0071675) | 2.23163191 |
132 | regulation of macrophage cytokine production (GO:0010935) | 2.22306153 |
133 | cytokine secretion (GO:0050663) | 2.21405586 |
134 | cellular response to ethanol (GO:0071361) | 2.20706086 |
135 | positive regulation of p38MAPK cascade (GO:1900745) | 2.20014573 |
136 | regulation of ARF protein signal transduction (GO:0032012) | 2.18469263 |
137 | negative regulation of lipid storage (GO:0010888) | 2.17723088 |
138 | regulation of cellular amide metabolic process (GO:0034248) | 2.17472413 |
139 | neutrophil chemotaxis (GO:0030593) | 2.16441506 |
140 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.16288809 |
141 | regulation of alkaline phosphatase activity (GO:0010692) | 2.15857802 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.63619145 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.14499283 |
3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.42198226 |
4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11212373 |
5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.95181391 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.76813813 |
7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74652792 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.69641295 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68801292 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66857168 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62796936 |
12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.52213454 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.33891740 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28049082 |
15 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20349052 |
16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18351186 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08205631 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01362764 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99865258 |
20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97406339 |
21 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.96361816 |
22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95039012 |
23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.93828681 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91245635 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84794262 |
26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74417683 |
27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70173839 |
28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64956665 |
29 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.64010884 |
30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62256245 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59332998 |
32 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59170238 |
33 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.52914008 |
34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45070828 |
35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44852421 |
36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43941278 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42827514 |
38 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42540213 |
39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42487654 |
40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40149552 |
41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38153157 |
42 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31628391 |
43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29909611 |
44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28340546 |
45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28203727 |
46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26603388 |
47 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25624231 |
48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25602281 |
49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25458559 |
50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25347364 |
51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23429187 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22398066 |
53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20107889 |
54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18363416 |
55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17286547 |
56 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16868848 |
57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16383936 |
58 | MAF_26560356_Chip-Seq_TH2_Human | 1.16379489 |
59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16263115 |
60 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15541161 |
61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15401772 |
62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15119443 |
63 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.12971924 |
64 | MAF_26560356_Chip-Seq_TH1_Human | 1.10497587 |
65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08830598 |
66 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08795399 |
67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08033758 |
68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06966269 |
69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05991616 |
70 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05658627 |
71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04629494 |
72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04329647 |
73 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.04181003 |
74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03486046 |
75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01428063 |
76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00662527 |
77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00398097 |
78 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00332325 |
79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00152740 |
80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00107896 |
81 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.99649048 |
82 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99133952 |
83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98829246 |
84 | MYB_26560356_Chip-Seq_TH2_Human | 0.97402215 |
85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96817504 |
86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96229264 |
87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94731870 |
88 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93953286 |
89 | MYB_26560356_Chip-Seq_TH1_Human | 0.93083464 |
90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92902810 |
91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92135946 |
92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91722467 |
93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91567492 |
94 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91398804 |
95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91326704 |
96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90496583 |
97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90313992 |
98 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.89676650 |
99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89564705 |
100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89564705 |
101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88099826 |
102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84916894 |
103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84224371 |
104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82491267 |
105 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82318643 |
106 | MYC_22102868_ChIP-Seq_BL_Human | 0.81813674 |
107 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81790167 |
108 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81458292 |
109 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81427903 |
110 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81424806 |
111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80541651 |
112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79512813 |
113 | UTX_26944678_Chip-Seq_JUKART_Human | 0.78073537 |
114 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78061339 |
115 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76374323 |
116 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76192481 |
117 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76178961 |
118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76116394 |
119 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75692873 |
120 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.75570225 |
121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75121494 |
122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73312159 |
123 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73174369 |
124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70946298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.00884097 |
2 | MP0001835_abnormal_antigen_presentation | 3.23329236 |
3 | MP0005058_abnormal_lysosome_morphology | 2.93940827 |
4 | MP0003436_decreased_susceptibility_to | 2.88543213 |
5 | MP0000569_abnormal_digit_pigmentation | 2.72327374 |
6 | MP0003300_gastrointestinal_ulcer | 2.68784768 |
7 | MP0003172_abnormal_lysosome_physiology | 2.59031899 |
8 | MP0005387_immune_system_phenotype | 2.57910444 |
9 | MP0001790_abnormal_immune_system | 2.57910444 |
10 | MP0002419_abnormal_innate_immunity | 2.46087594 |
11 | MP0006082_CNS_inflammation | 2.41121519 |
12 | MP0009840_abnormal_foam_cell | 2.38227559 |
13 | MP0008260_abnormal_autophagy | 2.33524211 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.31617405 |
15 | MP0004510_myositis | 2.31360537 |
16 | MP0005000_abnormal_immune_tolerance | 2.30395264 |
17 | MP0002139_abnormal_hepatobiliary_system | 2.23145337 |
18 | MP0005451_abnormal_body_composition | 2.22773387 |
19 | MP0005360_urolithiasis | 2.19800101 |
20 | MP0001800_abnormal_humoral_immune | 2.19596984 |
21 | MP0000604_amyloidosis | 2.16879951 |
22 | MP0009785_altered_susceptibility_to | 2.16028135 |
23 | MP0003075_altered_response_to | 2.14306922 |
24 | MP0002452_abnormal_antigen_presenting | 2.11307612 |
25 | MP0000685_abnormal_immune_system | 2.07957387 |
26 | MP0005025_abnormal_response_to | 2.02050978 |
27 | MP0003763_abnormal_thymus_physiology | 1.98752575 |
28 | MP0005464_abnormal_platelet_physiology | 1.97820588 |
29 | MP0002723_abnormal_immune_serum | 1.88560666 |
30 | MP0002148_abnormal_hypersensitivity_rea | 1.85166169 |
31 | MP0003690_abnormal_glial_cell | 1.84028541 |
32 | MP0005365_abnormal_bile_salt | 1.81197034 |
33 | MP0004947_skin_inflammation | 1.81167779 |
34 | MP0005083_abnormal_biliary_tract | 1.79942511 |
35 | MP0003252_abnormal_bile_duct | 1.79650157 |
36 | MP0003183_abnormal_peptide_metabolism | 1.72266830 |
37 | MP0005085_abnormal_gallbladder_physiolo | 1.70894709 |
38 | MP0003828_pulmonary_edema | 1.65706766 |
39 | MP0001533_abnormal_skeleton_physiology | 1.63923226 |
40 | MP0004859_abnormal_synaptic_plasticity | 1.63859251 |
41 | MP0004883_abnormal_blood_vessel | 1.63741910 |
42 | MP0002254_reproductive_system_inflammat | 1.63527913 |
43 | MP0009764_decreased_sensitivity_to | 1.63365376 |
44 | MP0001819_abnormal_immune_cell | 1.62287589 |
45 | MP0000858_altered_metastatic_potential | 1.61423381 |
46 | MP0002420_abnormal_adaptive_immunity | 1.60351359 |
47 | MP0001845_abnormal_inflammatory_respons | 1.56363027 |
48 | MP0003724_increased_susceptibility_to | 1.55984674 |
49 | MP0005166_decreased_susceptibility_to | 1.55103509 |
50 | MP0002138_abnormal_hepatobiliary_system | 1.54551772 |
51 | MP0003045_fibrosis | 1.52549667 |
52 | MP0005671_abnormal_response_to | 1.50365104 |
53 | MP0008469_abnormal_protein_level | 1.49979984 |
54 | MP0005310_abnormal_salivary_gland | 1.47751702 |
55 | MP0005167_abnormal_blood-brain_barrier | 1.45760278 |
56 | MP0010234_abnormal_vibrissa_follicle | 1.45618401 |
57 | MP0004858_abnormal_nervous_system | 1.42303776 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.40733231 |
59 | MP0009278_abnormal_bone_marrow | 1.34342881 |
60 | MP0000015_abnormal_ear_pigmentation | 1.33670713 |
61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32609821 |
62 | MP0010329_abnormal_lipoprotein_level | 1.31789852 |
63 | MP0009333_abnormal_splenocyte_physiolog | 1.31639984 |
64 | MP0004381_abnormal_hair_follicle | 1.31638612 |
65 | MP0010155_abnormal_intestine_physiology | 1.29074432 |
66 | MP0003866_abnormal_defecation | 1.26715051 |
67 | MP0003705_abnormal_hypodermis_morpholog | 1.25888402 |
68 | MP0008004_abnormal_stomach_pH | 1.25560288 |
69 | MP0001853_heart_inflammation | 1.23868591 |
70 | MP0002166_altered_tumor_susceptibility | 1.18690764 |
71 | MP0000609_abnormal_liver_physiology | 1.18627228 |
72 | MP0001851_eye_inflammation | 1.17283840 |
73 | MP0002405_respiratory_system_inflammati | 1.16575255 |
74 | MP0002006_tumorigenesis | 1.15447388 |
75 | MP0002998_abnormal_bone_remodeling | 1.15185261 |
76 | * MP0000716_abnormal_immune_system | 1.14549883 |
77 | MP0000703_abnormal_thymus_morphology | 1.07490979 |
78 | MP0003448_altered_tumor_morphology | 1.04474713 |
79 | MP0001666_abnormal_nutrient_absorption | 1.04150543 |
80 | MP0003091_abnormal_cell_migration | 1.04053704 |
81 | MP0005076_abnormal_cell_differentiation | 1.03734693 |
82 | MP0003195_calcinosis | 1.02334099 |
83 | MP0000343_altered_response_to | 1.01560363 |
84 | MP0004808_abnormal_hematopoietic_stem | 1.00231256 |
85 | MP0008961_abnormal_basal_metabolism | 0.99186952 |
86 | * MP0002398_abnormal_bone_marrow | 0.98699669 |
87 | * MP0000689_abnormal_spleen_morphology | 0.98072616 |
88 | MP0003566_abnormal_cell_adhesion | 0.95845552 |
89 | MP0002396_abnormal_hematopoietic_system | 0.95294020 |
90 | MP0002877_abnormal_melanocyte_morpholog | 0.95001407 |
91 | MP0009763_increased_sensitivity_to | 0.94714402 |
92 | MP0010352_gastrointestinal_tract_polyps | 0.94177122 |
93 | MP0002928_abnormal_bile_duct | 0.90960092 |
94 | MP0002132_abnormal_respiratory_system | 0.90844602 |
95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90834890 |
96 | MP0004130_abnormal_muscle_cell | 0.90664113 |
97 | MP0000371_diluted_coat_color | 0.88884142 |
98 | MP0002332_abnormal_exercise_endurance | 0.88735817 |
99 | MP0003453_abnormal_keratinocyte_physiol | 0.88190141 |
100 | MP0002118_abnormal_lipid_homeostasis | 0.87807208 |
101 | MP0001663_abnormal_digestive_system | 0.87717856 |
102 | MP0002136_abnormal_kidney_physiology | 0.86550454 |
103 | MP0003329_amyloid_beta_deposits | 0.86463686 |
104 | MP0001501_abnormal_sleep_pattern | 0.85435115 |
105 | * MP0002429_abnormal_blood_cell | 0.83546366 |
106 | MP0002909_abnormal_adrenal_gland | 0.82917346 |
107 | MP0001545_abnormal_hematopoietic_system | 0.82490697 |
108 | MP0005397_hematopoietic_system_phenotyp | 0.82490697 |
109 | MP0008874_decreased_physiological_sensi | 0.81540852 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.81259005 |
111 | MP0005164_abnormal_response_to | 0.81196994 |
112 | MP0003656_abnormal_erythrocyte_physiolo | 0.80471132 |
113 | MP0010307_abnormal_tumor_latency | 0.80211219 |
114 | MP0005409_darkened_coat_color | 0.79052792 |
115 | MP0002168_other_aberrant_phenotype | 0.78063583 |
116 | MP0003633_abnormal_nervous_system | 0.77736046 |
117 | MP0002090_abnormal_vision | 0.77027521 |
118 | MP0005174_abnormal_tail_pigmentation | 0.75973511 |
119 | MP0000249_abnormal_blood_vessel | 0.75463318 |
120 | MP0002009_preneoplasia | 0.74532121 |
121 | MP0002722_abnormal_immune_system | 0.74169430 |
122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71768041 |
123 | MP0005332_abnormal_amino_acid | 0.71422805 |
124 | MP0005390_skeleton_phenotype | 0.70097576 |
125 | MP0001873_stomach_inflammation | 0.69761492 |
126 | MP0006054_spinal_hemorrhage | 0.68794170 |
127 | MP0005257_abnormal_intraocular_pressure | 0.68502088 |
128 | MP0005075_abnormal_melanosome_morpholog | 0.68030598 |
129 | MP0003795_abnormal_bone_structure | 0.67564259 |
130 | MP0000920_abnormal_myelination | 0.63360464 |
131 | MP0002277_abnormal_respiratory_mucosa | 0.62079134 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 4.92491290 |
2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.60031070 |
3 | Recurrent abscess formation (HP:0002722) | 4.50289894 |
4 | Recurrent bacterial skin infections (HP:0005406) | 4.40076697 |
5 | Eczematoid dermatitis (HP:0000976) | 4.27857884 |
6 | Increased cerebral lipofuscin (HP:0011813) | 3.91531452 |
7 | Glomerulonephritis (HP:0000099) | 3.82625519 |
8 | Complement deficiency (HP:0004431) | 3.81053482 |
9 | T lymphocytopenia (HP:0005403) | 3.63975655 |
10 | Gastrointestinal infarctions (HP:0005244) | 3.47683170 |
11 | Myocardial infarction (HP:0001658) | 3.45211148 |
12 | Dysostosis multiplex (HP:0000943) | 3.33741936 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.33375486 |
14 | Abnormality of macrophages (HP:0004311) | 3.31429748 |
15 | Abnormality of T cell number (HP:0011839) | 3.30536684 |
16 | Abnormality of complement system (HP:0005339) | 3.25479761 |
17 | Prolonged bleeding time (HP:0003010) | 3.20587346 |
18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13874942 |
19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.10067264 |
20 | Mucopolysacchariduria (HP:0008155) | 3.10067264 |
21 | Autoimmune thrombocytopenia (HP:0001973) | 3.09632949 |
22 | Vacuolated lymphocytes (HP:0001922) | 3.09303110 |
23 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.08787724 |
24 | Keratoconjunctivitis sicca (HP:0001097) | 3.05771380 |
25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.99260914 |
26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.99260914 |
27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.99260914 |
28 | Epistaxis (HP:0000421) | 2.92735533 |
29 | Hematochezia (HP:0002573) | 2.91285561 |
30 | Colitis (HP:0002583) | 2.88530188 |
31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.85664237 |
32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.85664237 |
33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.85664237 |
34 | Nephritis (HP:0000123) | 2.85300604 |
35 | Gingivitis (HP:0000230) | 2.78429161 |
36 | Recurrent skin infections (HP:0001581) | 2.76829546 |
37 | Encephalitis (HP:0002383) | 2.76789587 |
38 | Keratoconjunctivitis (HP:0001096) | 2.75466924 |
39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.73744903 |
40 | Chest pain (HP:0100749) | 2.73491624 |
41 | Deep venous thrombosis (HP:0002625) | 2.73142092 |
42 | Cellulitis (HP:0100658) | 2.71116206 |
43 | Mitral stenosis (HP:0001718) | 2.68186643 |
44 | Recurrent viral infections (HP:0004429) | 2.65392841 |
45 | Hemoptysis (HP:0002105) | 2.65025391 |
46 | Axonal loss (HP:0003447) | 2.63236111 |
47 | Periodontitis (HP:0000704) | 2.61972782 |
48 | Abnormal platelet volume (HP:0011876) | 2.61320565 |
49 | Joint hemorrhage (HP:0005261) | 2.59297451 |
50 | Vasculitis (HP:0002633) | 2.59149234 |
51 | Recurrent fungal infections (HP:0002841) | 2.58399260 |
52 | Petechiae (HP:0000967) | 2.57033229 |
53 | Purpura (HP:0000979) | 2.54765795 |
54 | Disinhibition (HP:0000734) | 2.54102455 |
55 | Orchitis (HP:0100796) | 2.50561335 |
56 | Peritonitis (HP:0002586) | 2.48113658 |
57 | Leukocytosis (HP:0001974) | 2.46263042 |
58 | Interstitial pulmonary disease (HP:0006530) | 2.44918899 |
59 | Loss of speech (HP:0002371) | 2.42072795 |
60 | Gingival bleeding (HP:0000225) | 2.39293321 |
61 | Myositis (HP:0100614) | 2.38715335 |
62 | Slow saccadic eye movements (HP:0000514) | 2.36288884 |
63 | Inflammation of the large intestine (HP:0002037) | 2.33402932 |
64 | Arterial thrombosis (HP:0004420) | 2.32133207 |
65 | Subacute progressive viral hepatitis (HP:0006572) | 2.30833279 |
66 | Esophageal varix (HP:0002040) | 2.30480006 |
67 | Xanthomatosis (HP:0000991) | 2.30205621 |
68 | Stomatitis (HP:0010280) | 2.29482700 |
69 | Pustule (HP:0200039) | 2.24905516 |
70 | Abnormality of the common coagulation pathway (HP:0010990) | 2.24177966 |
71 | Increased IgE level (HP:0003212) | 2.23937902 |
72 | Retrobulbar optic neuritis (HP:0100654) | 2.22636396 |
73 | Optic neuritis (HP:0100653) | 2.22636396 |
74 | Increased mean platelet volume (HP:0011877) | 2.20844734 |
75 | Gastrointestinal inflammation (HP:0004386) | 2.20672905 |
76 | Anorexia (HP:0002039) | 2.19912038 |
77 | Thick nail (HP:0001805) | 2.19856731 |
78 | Abnormality of T cells (HP:0002843) | 2.19754036 |
79 | Abnormality of the fingertips (HP:0001211) | 2.19750160 |
80 | Increased CSF protein (HP:0002922) | 2.15067202 |
81 | Amyloidosis (HP:0011034) | 2.14383725 |
82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12325598 |
83 | Obstructive lung disease (HP:0006536) | 2.12325598 |
84 | Pulmonary infiltrates (HP:0002113) | 2.12186919 |
85 | Osteomyelitis (HP:0002754) | 2.11394720 |
86 | Episodic fever (HP:0001954) | 2.10297357 |
87 | Cerebral aneurysm (HP:0004944) | 2.09730762 |
88 | Tetraparesis (HP:0002273) | 2.07593050 |
89 | Upper motor neuron abnormality (HP:0002127) | 2.07189463 |
90 | Viral hepatitis (HP:0006562) | 2.06727084 |
91 | Global brain atrophy (HP:0002283) | 2.05846248 |
92 | Agammaglobulinemia (HP:0004432) | 2.01673684 |
93 | Meningitis (HP:0001287) | 1.99640000 |
94 | Spontaneous hematomas (HP:0007420) | 1.98586501 |
95 | Gangrene (HP:0100758) | 1.98231044 |
96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96966085 |
97 | Gastrointestinal stroma tumor (HP:0100723) | 1.94239088 |
98 | Menorrhagia (HP:0000132) | 1.94073976 |
99 | Abnormality of the peritoneum (HP:0002585) | 1.92888521 |
100 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.89751383 |
101 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89153530 |
102 | Chronic otitis media (HP:0000389) | 1.89070832 |
103 | Sepsis (HP:0100806) | 1.87043521 |
104 | Neuronal loss in central nervous system (HP:0002529) | 1.86334026 |
105 | Urticaria (HP:0001025) | 1.86216408 |
106 | Granulocytopenia (HP:0001913) | 1.86096318 |
107 | Peripheral demyelination (HP:0011096) | 1.85278706 |
108 | Mutism (HP:0002300) | 1.85121971 |
109 | Abnormality of the endocardium (HP:0004306) | 1.84915730 |
110 | Hypercholesterolemia (HP:0003124) | 1.84837668 |
111 | Arterial tortuosity (HP:0005116) | 1.84616461 |
112 | Recurrent bronchitis (HP:0002837) | 1.84256206 |
113 | Increased serum ferritin (HP:0003281) | 1.83173431 |
114 | Fatigue (HP:0012378) | 1.83168434 |
115 | Abnormality of the pleura (HP:0002103) | 1.82797533 |
116 | Epidermoid cyst (HP:0200040) | 1.82028900 |
117 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81943075 |
118 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81943075 |
119 | Glomerulopathy (HP:0100820) | 1.81548962 |
120 | Vertigo (HP:0002321) | 1.81328441 |
121 | Papilledema (HP:0001085) | 1.81088999 |
122 | Malnutrition (HP:0004395) | 1.79256699 |
123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79062781 |
124 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.78372225 |
125 | Osteolytic defects of the hand bones (HP:0009699) | 1.78372225 |
126 | Amaurosis fugax (HP:0100576) | 1.78272926 |
127 | Absent frontal sinuses (HP:0002688) | 1.78256973 |
128 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76991254 |
129 | Abnormality of the periventricular white matter (HP:0002518) | 1.76967316 |
130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.75629559 |
131 | Retinal atrophy (HP:0001105) | 1.74222429 |
132 | Eosinophilia (HP:0001880) | 1.73658858 |
133 | Prolonged partial thromboplastin time (HP:0003645) | 1.73212305 |
134 | Restrictive lung disease (HP:0002091) | 1.73032728 |
135 | Lymphopenia (HP:0001888) | 1.72860798 |
136 | Pulmonary embolism (HP:0002204) | 1.71656463 |
137 | Emphysema (HP:0002097) | 1.69863361 |
138 | Coarse hair (HP:0002208) | 1.69853021 |
139 | Thoracic kyphosis (HP:0002942) | 1.69359177 |
140 | Bone pain (HP:0002653) | 1.69024187 |
141 | Inappropriate behavior (HP:0000719) | 1.68688232 |
142 | Urethral obstruction (HP:0000796) | 1.67817699 |
143 | Spastic tetraparesis (HP:0001285) | 1.67505165 |
144 | Pathologic fracture (HP:0002756) | 1.66372265 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 3.99400886 |
2 | ERN1 | 2.96855992 |
3 | TYK2 | 2.73154278 |
4 | MAP3K13 | 2.64427626 |
5 | MAP3K14 | 2.49149467 |
6 | PRPF4B | 2.37186302 |
7 | TBK1 | 2.33491690 |
8 | MAP4K1 | 2.30064301 |
9 | MAP3K3 | 2.26695663 |
10 | JAK1 | 2.25464199 |
11 | BLK | 2.10702074 |
12 | MAP3K9 | 2.09789953 |
13 | TGFBR2 | 2.03456912 |
14 | TAOK3 | 1.87191108 |
15 | DAPK2 | 1.80453512 |
16 | CAMK1D | 1.79773253 |
17 | IRAK3 | 1.79126363 |
18 | CSF1R | 1.75792660 |
19 | RIPK1 | 1.74712474 |
20 | TXK | 1.64022102 |
21 | FES | 1.63567091 |
22 | CSK | 1.62960399 |
23 | IKBKE | 1.61603952 |
24 | CAMK1G | 1.57264581 |
25 | IRAK4 | 1.50208299 |
26 | EPHB1 | 1.47280029 |
27 | TRIB3 | 1.45008127 |
28 | SIK2 | 1.42090432 |
29 | FGR | 1.39848913 |
30 | MAP3K11 | 1.35349096 |
31 | KSR2 | 1.35166227 |
32 | PTK6 | 1.34904989 |
33 | MAP3K10 | 1.30286927 |
34 | IKBKB | 1.29532596 |
35 | HCK | 1.27065085 |
36 | YES1 | 1.27032309 |
37 | JAK3 | 1.26461624 |
38 | JAK2 | 1.24273812 |
39 | MATK | 1.24186603 |
40 | KIT | 1.22043184 |
41 | CAMKK1 | 1.21794576 |
42 | STK24 | 1.21363867 |
43 | SCYL2 | 1.19731285 |
44 | TNK2 | 1.15526455 |
45 | SYK | 1.15298445 |
46 | FGFR3 | 1.13971246 |
47 | FRK | 1.12675371 |
48 | FGFR4 | 1.12636897 |
49 | MST1R | 1.12171591 |
50 | SIK1 | 1.11081304 |
51 | GRK6 | 1.10919296 |
52 | SGK3 | 1.06410163 |
53 | BMX | 1.06128518 |
54 | PKN2 | 1.03047343 |
55 | IRAK1 | 1.01962318 |
56 | TAOK2 | 0.99772349 |
57 | STK10 | 0.98914446 |
58 | MAP3K2 | 0.97444567 |
59 | IRAK2 | 0.96630704 |
60 | MARK2 | 0.94672250 |
61 | CDC42BPA | 0.91992283 |
62 | CHUK | 0.90788911 |
63 | PIK3CG | 0.90402654 |
64 | PDK1 | 0.89825636 |
65 | TEC | 0.85222532 |
66 | EPHA4 | 0.85156892 |
67 | SIK3 | 0.84591622 |
68 | MARK3 | 0.83870145 |
69 | LYN | 0.83169485 |
70 | ZAP70 | 0.82956370 |
71 | CDK12 | 0.82857444 |
72 | NTRK3 | 0.81628187 |
73 | EGFR | 0.81339632 |
74 | PRKCH | 0.79605084 |
75 | PDPK1 | 0.79448838 |
76 | WNK1 | 0.76700850 |
77 | RET | 0.73016083 |
78 | LCK | 0.72911662 |
79 | ALK | 0.68839314 |
80 | MAP3K1 | 0.68656561 |
81 | BTK | 0.68222108 |
82 | FYN | 0.68115729 |
83 | MAP3K6 | 0.67295058 |
84 | LRRK2 | 0.66233537 |
85 | TAOK1 | 0.66118025 |
86 | ACVR1B | 0.63416342 |
87 | BMPR2 | 0.62722513 |
88 | DAPK1 | 0.62546815 |
89 | CAMKK2 | 0.61049362 |
90 | MAP3K7 | 0.59612804 |
91 | SGK2 | 0.58909672 |
92 | TRPM7 | 0.54753035 |
93 | PAK6 | 0.54270166 |
94 | PDGFRB | 0.53727336 |
95 | CDK6 | 0.53574703 |
96 | RPS6KC1 | 0.53439358 |
97 | RPS6KL1 | 0.53439358 |
98 | PIM1 | 0.52292235 |
99 | MAPK12 | 0.52238993 |
100 | ABL1 | 0.52036651 |
101 | SGK1 | 0.51698414 |
102 | MAP3K5 | 0.51547835 |
103 | DMPK | 0.50891876 |
104 | MAP2K4 | 0.49402905 |
105 | PRKCQ | 0.49355207 |
106 | NTRK1 | 0.48516651 |
107 | TTN | 0.48415496 |
108 | ITK | 0.48323636 |
109 | HIPK2 | 0.48081959 |
110 | MAPK7 | 0.47713694 |
111 | NEK9 | 0.47237382 |
112 | EPHA3 | 0.46985745 |
113 | MELK | 0.46374890 |
114 | RPS6KA6 | 0.44290045 |
115 | PRKD2 | 0.42725600 |
116 | MAP2K3 | 0.41527289 |
117 | GSK3A | 0.40651373 |
118 | STK38 | 0.40643293 |
119 | INSR | 0.40598767 |
120 | GRK7 | 0.40538568 |
121 | PRKCD | 0.40097466 |
122 | STK11 | 0.39891264 |
123 | PTK2B | 0.39244970 |
124 | CAMK4 | 0.37592351 |
125 | IGF1R | 0.36391377 |
126 | MOS | 0.34533841 |
127 | STK3 | 0.33037970 |
128 | PRKAA2 | 0.32819908 |
129 | KSR1 | 0.32774396 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.26732124 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.48955914 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.29225298 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04148252 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04055410 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96981437 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83157784 |
8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72383460 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 1.63799106 |
10 | Pertussis_Homo sapiens_hsa05133 | 1.60268125 |
11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.58955839 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.58545350 |
13 | Lysosome_Homo sapiens_hsa04142 | 1.54320262 |
14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45938480 |
15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44803095 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44364943 |
17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38213330 |
18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32173122 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28792830 |
20 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27921505 |
21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26057923 |
22 | Malaria_Homo sapiens_hsa05144 | 1.25628409 |
23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23665993 |
24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21706011 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20851876 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17059986 |
27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14914515 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14462297 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.13631409 |
30 | Influenza A_Homo sapiens_hsa05164 | 1.13604600 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13418866 |
32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12173530 |
33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08967949 |
34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06357100 |
35 | Measles_Homo sapiens_hsa05162 | 1.05578001 |
36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05149809 |
37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04969844 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99860998 |
39 | Prion diseases_Homo sapiens_hsa05020 | 0.96595891 |
40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94363772 |
41 | Salmonella infection_Homo sapiens_hsa05132 | 0.92386672 |
42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90810001 |
43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88747852 |
44 | Phagosome_Homo sapiens_hsa04145 | 0.88522605 |
45 | Amoebiasis_Homo sapiens_hsa05146 | 0.86650520 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86138729 |
47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84149287 |
48 | Bile secretion_Homo sapiens_hsa04976 | 0.83318123 |
49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82744619 |
50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80798668 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 0.79735448 |
52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79150767 |
53 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79006659 |
54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76996576 |
55 | ABC transporters_Homo sapiens_hsa02010 | 0.75967115 |
56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75744325 |
57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75072767 |
58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74985235 |
59 | Insulin resistance_Homo sapiens_hsa04931 | 0.74480967 |
60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74408504 |
61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73865948 |
62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72818347 |
63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72796982 |
64 | Shigellosis_Homo sapiens_hsa05131 | 0.72510791 |
65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71946490 |
66 | Hepatitis B_Homo sapiens_hsa05161 | 0.71065828 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71043637 |
68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70327180 |
69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70216780 |
70 | Glioma_Homo sapiens_hsa05214 | 0.69952710 |
71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69119464 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67759789 |
73 | Apoptosis_Homo sapiens_hsa04210 | 0.67249588 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.67230659 |
75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65900274 |
76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65722018 |
77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64180963 |
78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63565649 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63497522 |
80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62275277 |
81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61858261 |
82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61854039 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60910385 |
84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60448674 |
85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59763900 |
86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59461914 |
87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59121737 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58038308 |
89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57489638 |
90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57041219 |
91 | Allograft rejection_Homo sapiens_hsa05330 | 0.55686924 |
92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55529548 |
93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54946602 |
94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54617678 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.53299875 |
96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52735044 |
97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50626412 |
98 | Salivary secretion_Homo sapiens_hsa04970 | 0.49645415 |
99 | Bladder cancer_Homo sapiens_hsa05219 | 0.49010911 |
100 | Endocytosis_Homo sapiens_hsa04144 | 0.48030697 |
101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47389348 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47315659 |
103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47202019 |
104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46177945 |
105 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.45980952 |
106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45616039 |
107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45455009 |
108 | Asthma_Homo sapiens_hsa05310 | 0.45399467 |
109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45303849 |
110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45146207 |
111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45096735 |
112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44672818 |
113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44511743 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44243205 |
115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43875544 |
116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43075048 |
117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41810641 |
118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41479977 |
119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40955427 |
120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40644890 |
121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39916226 |
122 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39630019 |
123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39307996 |
124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39112329 |